{"id":431849,"title":"Nitrosamine impurities in medications: Guidance  - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-02","captureTimestamp":"2026-01-02T06:47:48.987000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/information-health-product/drugs/nitrosamine-impurities/medications-guidance.html","snippet":"Nitrosamine impurities in medications: Guidance Overview Recalls Test methods and test results Guidance Established acceptable intake limits Report a problem or concern Download in PDF format (1.37 MB, 52 pages) Organization: Health Canada Date published: 2022-04-04 Date updated:…","rawSnapshotUrl":"/api/snapshots/raw/431849","browseUrl":"https://replay.healtharchive.ca/job-6/20260102064748/https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/information-health-product/drugs/nitrosamine-impurities/medications-guidance.html#ha_snapshot=431849","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}